US Patent Family Members and Approved Drugs for Ireland Patent: 862317
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Ireland Patent: IE862317
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 5,618,913 | 2014-04-08 | insulin aspart | Novo Nordisk Inc. | NOVOLOG |
| 5,618,913 | 2014-04-08 | insulin detemir | Novo Nordisk Inc. | LEVEMIR |
| 5,618,913 | 2014-04-08 | insulin aspart protamine and insulin aspart | Novo Nordisk Inc. | NOVOLOG MIX 50/50 |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
